Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective

. 2021 Nov 15 ; 235 () : 121315. [epub] 20210630

Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid34226789
Odkazy

PubMed 34226789
PubMed Central PMC8245053
DOI 10.1016/j.energy.2021.121315
PII: S0360-5442(21)01563-2
Knihovny.cz E-zdroje

Vaccination now offers a way to resolve the COVID-19 pandemic. However, it is critical to recognise the full energy, environmental, economic and social equity (4E) impacts of the vaccination life cycle. The full 4E impacts include the design and trials, order management, material preparation, manufacturing, cold chain logistics, low-temperature storage, crowd management and end-of-life waste management. A life cycle perspective is necessary for sustainable vaccination management because a prolonged immunisation campaign for COVID-19 is likely. The impacts are geographically dispersed across sectors and regions, creating real and virtual 4E footprints that occur at different timescales. Decision-makers in industry and governments have to act, unify, resolve, and work together to implement more sustainable COVID-19 vaccination management globally and locally to minimise the 4E footprints. Potential practices include using renewable energy in production, storage, transportation and waste treatment, using better product design for packaging, using the Internet of Things (IoT) and big data analytics for better logistics, using real-time database management for better tracking of deliveries and public vaccination programmes, and using coordination platforms for more equitable vaccine access. These practices raise global challenges but suggest solutions with a 4E perspective, which could mitigate the impacts of global vaccination campaigns and prepare sustainably for future pandemics and global warming.

Zobrazit více v PubMed

WHO . 2021. WHO coronavirus (COVID-19) dashboard.https://covid19.who.int

Mofijur M., Fattah I.R., Alam M.A., Islam A.S., Ong H.C., Rahman S.A., Mahlia T.M.I. Impact of COVID-19 on the social, economic, environmental and energy domains: lessons learnt from a global pandemic. Sustain Prod Consump. 2021;26:343–359. PubMed PMC

Tiba S., Omri A. Literature survey on the relationships between energy, environment and economic growth. Renew Sustain Energy Rev. 2017;69:1129–1146.

Jiang P., Van Fan Y., Klemeš J.J. Impacts of COVID-19 on energy demand and consumption: challenges, lessons and emerging opportunities. Appl Energy. 2021;285:116441. PubMed PMC

Zambrano-Monserrate M.A., Ruano M.A., Sanchez-Alcalde L. Indirect effects of COVID-19 on the environment. Sci Total Environ. 2020;728:138813. PubMed PMC

Ozili P.K., Arun T. 2020. Spillover of COVID-19: impact on the global economy. Available at: SSRN 3562570.

Van Bavel J.J., Baicker K., Boggio P.S., Capraro V., Cichocka A., Cikara M., Willer R. Using social and behavioural science to support COVID-19 pandemic response. Nat Human Behav. 2020;4(5):460–471. PubMed

Zimmer C., Corum J., Wee S.L. 2021. Covid-19 vaccine tracker. The New York times.https://www.nytimes.com/interactive/2020/science/coronavirus-vaccinetracker.html

Moutinho S. Brazilian town experiment shows mass vaccination can wipe out COVID-19. Science. 2021 doi: 10.1126/science.abj7815. DOI

Our World in Data . 2021. Coronavirus (COVID-19) vaccinations.https://ourworldindata.org/covid-vaccinations

Loomba S., de Figueiredo A., Piatek S.J., de Graaf K., Larson H.J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Human Behav. 2021;5(3):337–348. PubMed

Sandmann F.G., Davies N.G., Vassall A., Edmunds W.J., Jit M., Sun F.Y., Klepac P. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00079-7. PubMed DOI PMC

Yu D.E.C., Razon L.F., Tan R.R. Can global pharmaceutical supply chains scale up sustainably for the COVID-19 crisis? Resour Conserv Recycl. 2020;159:104868. PubMed PMC

Ortiz-Prado E., Espín E., Vásconez J., Rodríguez-Burneo N., Kyriakidis N.C., López-Cortés A. Vaccine market and production capabilities in the Americas. Tropical Diseases, Travel Medicine and Vaccines. 2021;7:11. doi: 10.1186/s40794-021-00135-5. PubMed DOI PMC

Excler J.L., Privor-Dumm L., Kim J.H. Supply and delivery of vaccines for global health. Curr Opin Immunol. 2021;71:13–20. PubMed PMC

Klemeš J.J., Van Fan Y., Tan R.R., Jiang P. Minimising the present and future plastic waste, energy and environmental footprints related to COVID-19. Renew Sustain Energy Rev. 2020;127:109883. PubMed PMC

DHL . 2020. Delivering pandemic resilience: how to secure stable supply chains for vaccines and medical goods during the covid-19 crisis and future health emergencies.https://www.dhl.com/content/dam/dhl/global/core/documents/pdf/glo-core-delivering-pandemic-resilience-2020.pdf

Santos A.F., Gaspar P.D., de Souza H.J. Refrigeration of COVID-19 vaccines: ideal storage characteristics, energy efficiency and environmental impacts of various vaccine options. Energies. 2021;14(7):1849.

Lloyd J., McCarney S., Ouhichi R., Lydon P., Zaffran M. Optimizing energy for a ‘green’ vaccine supply chain. Vaccine. 2015;33(7):908–913. PubMed PMC

Skegg D., Gluckman P., Boulton G., Hackmann H., Karim S.S.A., Piot P., Woopen C. Future scenarios for the COVID-19 pandemic. Lancet. 2021;397:777–778. 10276. PubMed PMC

Cohen J., Kupferschmidt K. As vaccines emerge, a global waiting game begins. Science. 2020;370(6523):1385–1387. PubMed

Muller A. How COVID vaccines are being divvied up around the world. Nature. 2020 doi: 10.1038/d41586-020-03370-6. PubMed DOI

Fontanet A., Autran B., Lina B., Kieny M.P., Karim S.S.A., Sridhar D. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet. 2021;397:952–954. 10278. PubMed PMC

Cohen J. South Africa suspends use of AstraZeneca's COVID-19 vaccine after it fails to clearly stop virus variant. Science. 2021 doi: 10.1126/science.abg9559. DOI

Hodgson D., Flasche S., Jit M., Kucharski A.J., CMMID COVID-19 Working Group The potential for vaccination-induced herd immunity against the SARS-CoV-2 B. 1.1. 7 variant. Euro Surveill. 2021;26(20):2100428. PubMed PMC

Moutinho S. Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States. Science. 2021 doi: 10.1126/science.abi6931. DOI

Schiffling S., Breen L. 2021. COVID vaccine: some waste is normal – but here's how it is being kept to a minimum.https://theconversation.com/covid-vaccine-some-waste-is-normal-but-heres-how-it-is-being-kept-to-a-minimum-152772

Lee T.H., Chen A.H. Last-mile logistics of covid vaccination—the role of health care organisations. N Engl J Med. 2021;384(8):685–687. PubMed

Subramanian L., Nayler J. Pamela Steele Associates Ltd; 2021. Africa's covid-19 vaccine supply chain and logistics readiness.https://www.pamsteele.co.uk/wp-content/uploads/2021/03/20210308_Africa_Covid_Vaccine_Logistics_Final.pdf

Li T., Huang T., Guo C., Wang A., Shi X., Mo X., et al. 2021. Genomic variation, origin tracing and vaccine development of SARS-CoV-2: a systematic review. The innovation; p. 100116. PubMed PMC

Reuters . 2021. Explained: a list of countries vaccinating children against Covid-19.https://indianexpress.com/article/explained/global-covid-vaccination-drive-for-children-7340799

Callaway E. COVID vaccines and kids: five questions as trials begin. Nature. 2021;592:670–671. PubMed

Adyel T.M. Accumulation of plastic waste during COVID-19. Science. 2020;369(6509):1314–1315. PubMed

Klemeš J.J., Fan Y.V., Jiang P. The energy and environmental footprints of COVID-19 fighting measures–PPE, disinfection, supply chains. Energy. 2020;211:118701. PubMed PMC

Jóźwiak G. 2021. The looming waste crisis that will follow COVID-19 vaccinations.https://www.devex.com/news/the-looming-waste-crisis-that-will-follow-covid-19-vaccinations-99578

Wouters O.J., Shadlen K.C., Salcher-Konrad M., Pollard A.J., Larson H.J., Teerawattananon Y., Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397:1023–1034. 10278. PubMed PMC

Nhamo G., Chikodzi D., Kunene H.P., Mashula N. COVID-19 vaccines and treatments nationalism: challenges for low-income countries and the attainment of the SDGs. Global Publ Health. 2021;16(3):319–339. PubMed

ICC International chamber of commerce (ICC) Eco Case Global Vaccin. 2021 https://iccwbo.org/publication/the-economic-case-for-global-vaccinations

Çakmaklı C., Demiralp S., Kalemli-Özcan Ṣ., Yeşiltaş S., Yıldırım M.A. National Bureau of Economic Research; 2021. The economic case for global vaccinations: an epidemiological model with international production networks (No. w28395)

Duke Global Health Innovation Center . 2021. Vaccine procurement.https://launchandscalefaster.org/covid-19/vaccineprocurement

Siu T., Kaye B., Siu T., Busvine D., Nebehay S. 2021. Unwanted vaccines needed to help poor countries catch up, international health officials say.https://www.reuters.com/world/countries-emphasise-importance-astrazeneca-shot-they-look-alternatives-2021-04-09

Editorial How science can put the Sustainable Development Goals back on track. Nature. 2021;589:329–330. doi: 10.1038/d41586-021-00104-0. PubMed DOI

Lazarus J.V., Ratzan S.C., Palayew A., Gostin L.O., Larson H.J., Rabin K., et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228. PubMed PMC

Forman R., Shah S., Jeurissen P., Jit M., Mossialos E. COVID-19 Vaccine Challenges: what have we learned so far and what remains to be done? Health Pol. 2021;125(5):553–567. PubMed PMC

Barnabas R.V., Wald A. A public health COVID-19 vaccination strategy to maximise the health gains for every single vaccine dose. Ann Intern Med. 2021 doi: 10.7326/M20-8060. PubMed DOI PMC

Moore S., Hill E.M., Tildesley M.J., Dyson L., Keeling M.J. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;21(6):793–802. PubMed PMC

CNA . 2021. Pfizer-BioNTech COVID-19 vaccine can be stored in refrigerator for a month, US says.https://www.channelnewsasia.com/news/pfizer-biontech-covid-19-vaccine-refrigerator-store-temperature-14846392?cid=h3_referral_inarticlelinks_24082018_cna

Tham T. 2021. Singapore approves storage of Pfizer-BioNTech COVID-19 vaccine at refrigerator temperatures.https://www.channelnewsasia.com/news/singapore/singapore-pfizer-biontech-covid-19-vaccine-fridge-storage-14880958

Reuters . 2021. UK regulator says Pfizer COVID vaccine can be stored 31 days in fridge.https://www.reuters.com/world/uk/uk-regulator-says-pfizer-covid-vaccine-can-be-stored-31-days-fridge-2021-05-20

Ng E. 2021. Several countries delaying second Covid-19 vaccine dose.https://www.straitstimes.com/world/several-countries-delaying-second-covid-19-vaccine-dose

Enayati S., Özaltın O.Y. Optimal influenza vaccine distribution with equity. Eur J Oper Res. 2020;283(2):714–725.

Monod M., Blenkinsop A., Xi X., Hebert D., Bershan S., Tietze S., Ratmann O. Age groups that sustain resurging COVID-19 epidemics in the United States. Science. 2021;371(6536) PubMed PMC

Shaw R.H., Stuart A., Greenland M., Liu X., Van-Tam J.S.N., Snape M.D. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet. 2021;397:2043–2046. 10289. PubMed PMC

Acharya K.P., Ghimire T.R., Subramanya S.H. Access to and equitable distribution of COVID-19 vaccine in low-income countries. npj Vaccines. 2021;6(1):1–3. PubMed PMC

WHO . 2021. COVAX. Working for global equitable access to COVID-19 vaccines.https://www.who.int/initiatives/act-accelerator/covax

United Nations . 2021. Low-income countries have received just 0.2 per cent of all COVID-19 shots given.https://news.un.org/en/story/2021/04/1089392

Global Times . 2021. A COVID-19 nasal spray vaccine applies for emergency use in China.http://en.people.cn/n3/2021/0604/c90000-9857634.html

Cao M., Su X., Jiang S. Broad-spectrum anti-coronavirus vaccines and therapeutics to combat the current COVID-19 pandemic and future coronavirus disease outbreaks. Stem Cell Reports. 2021;16(3):398–411. PubMed PMC

Holder J. 2021. Tracking coronavirus vaccinations around the world. The New York times.https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html

Khubchandani J., Sharma S., Price J.H., Wiblishauser M.J., Sharma M., Webb F.J. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–277. PubMed PMC

Hussain A., Sheikh A. Opportunities for artificial intelligence–enabled social media analysis of public attitudes toward Covid-19 vaccines. NEJM Catalyst Innovations in Care Delivery. 2021;2(1) doi: 10.1056/CAT.20.0649. DOI

Wang J., Lu X., Lai X., Lyu Y., Zhang H., Fenghuang Y., Fang H. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study. Vaccines. 2021;9(3):191. PubMed PMC

Michie S., West R. Sustained behavior change is key to preventing and tackling future pandemics. Nat Med. 2021;27:749–752. PubMed

Perera A.T.D., Nik V.M., Chen D., Scartezzini J.L., Hong T. Quantifying the impacts of climate change and extreme climate events on energy systems. Nature Energy. 2020;5(2):150–159.

Klemeš J.J., Jiang P., Fan Y.V., Bokhari A., Wang X.-C. COVID-19 pandemics stage II – energy and environmental impacts of vaccination. Renew Sustain Energy Rev. 2021 doi: 10.1016/j.rser.2021.111400. 111400. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...